Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Volume 3, 2012

Volume 3, Issue 1 pp 1-111	Volume 3, Issue 2 pp 112-223	Volume 3, Issue 3 pp 224-358	Volume 3, Issue 4 pp 359-513	Volume 3, Issue 5 pp 514-593
Volume 3, Issue 6 pp 594-663	Volume 3, Issue 7 pp 664-734	Volume 3, Issue 8 pp 735-906	Volume 3, Issue 9 pp 907-1048	Volume 3, Issue 10 pp 1049-1258
Volume 3, Issue 11 pp 1259-1482	Volume 3, Issue 12 pp 1483-1724

Publication Alerts

Post-Publication Promotion

Publication Discount

Volume 3, 2012